INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Grant or awardVerified data

Ribeiro Ramiro reported EYPT

Chief Medical Officer · EyePoint, Inc. · EyePoint, Inc. — Stock Option (Right to Buy)

Side
A
Value
—
Shares
171.4K
Price
—
Executed
Jan 2, 2026
Disclosed
Jan 6, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 2 executedJan 6, 2026 disclosed

EYPT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
5/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · EYPT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,437 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    7
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,438 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    9
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,437 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    13
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,438 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,437 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,438 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    13
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,437 sh
    		Apr 17, 2026Apr 20, 2026
    traded Apr 17, 2026
    		+3dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,437 sh
    		Apr 17, 2026Apr 20, 2026
    traded Apr 17, 2026
    		+3dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,437 sh
    		Apr 17, 2026Apr 20, 2026
    traded Apr 17, 2026
    		+3dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,438 sh
    		Mar 4, 2026Mar 5, 2026
    traded Mar 4, 2026
    		+1dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,438 sh
    		Mar 4, 2026Mar 5, 2026
    traded Mar 4, 2026
    		+1dSEC FORM 4

    Evidence

    13
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$44K
    2,438 sh
    		Mar 4, 2026Mar 5, 2026
    traded Mar 4, 2026
    		+1dSEC FORM 4

    Evidence

    13
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,437 sh
    		Feb 17, 2026Feb 18, 2026
    traded Feb 17, 2026
    		+1dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,437 sh
    		Feb 17, 2026Feb 18, 2026
    traded Feb 17, 2026
    		+1dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,437 sh
    		Feb 17, 2026Feb 18, 2026
    traded Feb 17, 2026
    		+1dSEC FORM 4

    Evidence

    7
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    29.3K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    19
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$727K
    42.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    10
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$242K
    29.3K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    17
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise
    		M—
    19.7K sh
    		Jan 3, 2026Jan 6, 2026
    traded Jan 3, 2026
    		+3dSEC FORM 4

    Evidence

    9
    SJ
    Sanders Reginald J.Director
    EYPTEyePoint, Inc.
    Grant or award
    		A—
    40.0K sh
    		Jan 2, 2026Jan 6, 2026
    traded Jan 2, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002013623-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 2, 2026
    Published
    Jan 6, 2026
    Ingested by INSIDER
    Nov 5, 04:24 UTC
    Last re-read
    Nov 5, 04:24 UTC

    Extracted facts

    Filer
    Ribeiro Ramiro
    Role
    Chief Medical Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    EyePoint, Inc. — Stock Option (Right to Buy)
    Ticker
    EYPT
    Shares
    171.4K
    Price per share
    $0
    Execution date (reported)
    Jan 2, 2026
    Owned after transaction
    171.4K shares
    Days from execution to publication
    4

    What this establishes

    Ribeiro Ramiro filed this Form 4 reporting a grant or award of EYPT on Jan 2, 2026. It became public on Jan 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Medical Officer
    Ribeiro Ramirocik:0002013623
    Issuer
    EyePoint, Inc.cik:0001314102

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.